⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplementary Figure S6 from Prognostic markers of DNA methylation and NGS sequencing in progressive glioblastoma from the EORTC-26101 trial

Tobias Keßler Daniel Schrimpf Laura Doerner Ling Hai Leon D. Kaulen Jakob Ito Martin J. van den Bent Martin Taphoorn Alba A. Brandes Ahmed Idbaïh Julien Dômont Paul M. Clément Mario Campone Martin Bendszus Andreas von Deimling Felix Sahm Michael Platten Wolfgang Wick Antje Wick

View at Publisher

Ask AI

Bookmark

Share

Abstract

Supplementary Figure 6: Overall Survival according to PTEN mutation status in the group of IDH-wildtype glioblastomas (n = 362).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Keßler et al. (2024) studied this question.

synapsesocial.com/papers/68e586c1b6db64358752390a https://doi.org/10.1158/1078-0432.27033682.v1

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S6 from Prognostic markers of DNA methylation and NGS sequencing in progressive glioblastoma from the EORTC-26101 trial2024
2Supplementary Figure S2 from Prognostic markers of DNA methylation and NGS sequencing in progressive glioblastoma from the EORTC-26101 trial2024
3Supplementary Figure S2 from Prognostic markers of DNA methylation and NGS sequencing in progressive glioblastoma from the EORTC-26101 trial2024
4Supplementary Figure S7 from Prognostic markers of DNA methylation and NGS sequencing in progressive glioblastoma from the EORTC-26101 trial2024
5Supplementary Figure S7 from Prognostic markers of DNA methylation and NGS sequencing in progressive glioblastoma from the EORTC-26101 trial2024

Supplementary Figure S4 from Prognostic markers of DNA methylation and NGS sequencing in progressive glioblastoma from the EORTC-26101 trial2024
Supplementary Figure S4 from Prognostic markers of DNA methylation and NGS sequencing in progressive glioblastoma from the EORTC-26101 trial2024
Supplementary Figure S1 from Prognostic markers of DNA methylation and NGS sequencing in progressive glioblastoma from the EORTC-26101 trial2024